Answers are grounded in this paper and cite their sources.
BACKGROUND: Since the beginning of corona virus disease 2019 (COVID-19) pandemic, there has been a widespread use of remdesivir in adults and children. There is little known information about its outcomes in patients with end stage renal disease who are on dialysis. AIM: To assess the clinical outcomes with use of remdesivir in adult patients with end stage kidney failure on hemodialysis. METHODS: A retrospective, multicenter study was conducted on patients with end stage renal disease on hemodialysis that were discharged after treatment for COVID-19 between April 1, 2020 and December 31, 2020. Primary endpoints were oxygen requirements, time to mortality and escalation of care needing mechanical ventilation. CONCLUSION: Larger studies are justified to study the effects of remdesivir in this high-risk population with end stage kidney disease on dialysis.
No takes yet. Share an insight, caveat, or question.
Selvaraj et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: